Integrative machine learning analysis of bulk and single-nucleus RNA sequencing reveals key cell types and biomarkers driving MASH-associated fibrosis
BackgroundMetabolic dysfunction-associated steatohepatitis (MASH) increases the risk of cirrhosis and liver cancer, with liver fibrosis being the primary determinant of adverse outcomes.